TrialJournal of cancer research and clinical oncology2023

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial.

K Alsaleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.